Patient-Reported Health Status Assessment Using the KCCQ for Early Detection of Heart Failure Worsening

Recruiting Observational Study
Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
120 (estimated)
Sponsor
I.M. Sechenov First Moscow State Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This observational feasibility study aims to assess (i) how practical and acceptable repeated KCCQ assessments are; (ii) the connection between changes over time in KCCQ scores and signs of congestion; and (iii) clinical outcomes, including worsening heart failure events or cardiovascular death (CVD), and the time between 5- and 10-point KCCQ changes and clinical events.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Established diagnosis of chronic HF with reduced, mildly reduced, or preserved ejection fraction, NYHA II-III * History of heart failure (HF) hospitalization within the last 6 months before enrollment, defined as the presence of dyspnea, elevated NT-proBNP ≥300 pg/mL (sinus rh…
Contacts

Anastasia Shchendrygina

+79262309207

a.shchendrygina@gmail.com

CONTACT

Svetlana Rachina

rachina_s_a@staff.sechenov.ru

CONTACT